Hepatitis C and autoimmunity: A therapeutic challenge

7Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Böckle BC, Baltaci M, Ratzinger G, Graziadei I, Vogel W, Sepp NT (Innsbruck Medical University, Anichstrasse, Innsbruck, Austria). Hepatitis C and autoimmunity: a therapeutic challenge (Case Report). J Intern Med 2012; 271: 104-106. Hepatitis C virus (HCV) infection causes not only acute and chronic liver disease, but also extrahepatic symptoms. To our knowledge, this is the first case report of a patient who developed simultaneously subacute cutaneous lupus erythematosus and a small CD20+ B-cell clone because of chronic HCV infection and relapse after standard of care therapy (pegylated interferon plus ribavirin). Treatment with rituximab, a chimeric anti-CD20 monoclonal antibody, was successful. © 2011 The Association for the Publication of the Journal of Internal Medicine.

Cite

CITATION STYLE

APA

Böckle, B. C., Baltaci, M., Ratzinger, G., Graziadei, I., Vogel, W., & Sepp, N. T. (2012). Hepatitis C and autoimmunity: A therapeutic challenge. Journal of Internal Medicine, 271(1), 104–106. https://doi.org/10.1111/j.1365-2796.2011.02391.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free